Related Experiment Video
Updated: Jul 8, 2026
08:19
Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Endolysins and Their Potential in Combating Bacterial Multidrug Resistance
Olga I Guliy1, Olga A Karavaeva1
1Institute of Biochemistry and Physiology of Plants and Microorganisms - Subdivision of the Federal State Budgetary Research Institution Saratov Federal Scientific Centre of the Russian Academy of Sciences (IBPPM RAS), 410049 Saratov, Russia.
Frontiers in Bioscience (Elite Edition)
|July 7, 2026
Summary
Bacteriophage endolysins show promise as novel antibacterial agents to combat rising antibiotic resistance and bacterial infections, including biofilms. Their therapeutic potential is being explored alongside innovative strategies like artificial intelligence.
Area of Science:
- Microbiology and Infectious Diseases
- Biotechnology and Drug Discovery
Background:
- Antibiotic resistance is a growing global health crisis, with multidrug-resistant pathogens causing millions of deaths annually.
- Traditional antibiotics face limitations due to widespread bacterial resistance, necessitating the exploration of novel therapeutic strategies.
- Bacteriophage-derived enzymes, specifically endolysins, are emerging as potent alternatives to conventional antibiotics.
Purpose of the Study:
- To review the achievements and mechanisms of bacteriophage endolysins against bacterial infections.
- To discuss the therapeutic potential of endolysins in overcoming antibiotic resistance and combating biofilms.
- To explore novel strategies, including combination therapies and artificial intelligence, for antimicrobial-resistant infections.
Main Methods:
- Comprehensive literature review of bacteriophage endolysins and their antibacterial properties.
- Analysis of endolysin mechanisms of action against various bacterial pathogens and biofilms.
- Discussion of current research trends and future therapeutic applications.
Main Results:
- Bacteriophage endolysins demonstrate potent lytic activity against a broad spectrum of bacteria, including multidrug-resistant strains.
- Endolysins are effective against bacterial biofilms, a significant challenge in treating chronic infections.
- Emerging research highlights the potential of combining endolysins with other molecules and leveraging AI for enhanced efficacy.
Conclusions:
- Bacteriophage endolysins represent a promising class of nonclassical antibiotics with significant therapeutic potential against resistant bacteria.
- Further research and clinical trials are warranted to fully realize the clinical application of endolysins.
- Innovative approaches, including combination therapies and AI, are crucial for addressing the escalating threat of antimicrobial resistance.
Related Concept Videos
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...